首页> 美国卫生研究院文献>other >Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumanni agents
【2h】

Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumanni agents

机译:4-(4-甲酰基-3-苯基-1H-吡唑-1-基)苯甲酸新型衍生物作为强抗鲍曼不动杆菌的合成及抗菌研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microbial resistance to antibiotics is a global concern. The World Health Organization (WHO) has identified antimicrobial resistance as one the three greatest threats for human beings in the 21st century. Without urgent and coordinated action, the world is moving toward a post-antibiotic era, in which normal infections or minor injuries may become fatal. In an effort to find new agents, we report the synthesis and antimicrobial activities of 40 novel 1,3-diphenyl pyrazole derivatives. These compounds have shown zones of growth inhibition up to 85 mm against Acinetobacter baumannii. We tested the active compounds against this Gram-negative bacterium in minimum inhibitory concentration (MIC) tests and found activity with concentration as low as 4 μg/mL.
机译:微生物对抗生素的耐药性是全球关注的问题。世界卫生组织(WHO)已将抗菌素耐药性确定为21世纪人类面临的三大威胁。如果没有紧急和协调的行动,世界将进入抗生素时代之后,在该时代,正常感染或轻伤可能致命。为了寻找新的药物,我们报告了40种新型1,3-二苯基吡唑衍生物的合成和抗菌活性。这些化合物已显示出针对鲍曼不动杆菌的生长抑制区,最高可达85 mm。我们在最小抑制浓度(MIC)测试中针对该革兰氏阴性细菌测试了活性化合物,发现其活性低至4μg/ mL。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号